Noom Pricing Analysis & Total Cost: What You Actually Pay in 2026

What Noom's Coaching Plan Actually Costs

The base Noom subscription is a behavioral weight loss coaching program delivered through a mobile app. Pricing depends entirely on which billing cycle you commit to at sign-up.

As of early 2026, Noom's published pricing tiers work out as follows: the monthly plan costs approximately $70 per month, the 4-month plan drops to about $42 per month, and the annual plan bills at $209 upfront (roughly $17 per month). A 14-day free trial is offered, but it auto-converts to a paid subscription if not canceled. That auto-enrollment model has generated significant consumer complaints, a point we address below.

These prices position Noom in the mid-range of digital weight management platforms. WeightWatchers Digital costs $23 per month on an annual plan, while Calibrate's metabolic health program runs $135 to $249 per month 1. The cost gap widens when you factor in what Noom does and does not include. The base coaching subscription provides daily lessons rooted in cognitive behavioral therapy (CBT) principles, food logging, a group support feature, and access to a non-clinical "coach" who communicates via text. It does not include one-on-one sessions with a dietitian, physician consultations, lab work, or medication.

One important distinction: Noom's "coaches" are not licensed therapists, registered dietitians, or physicians. A 2022 analysis published in the Journal of Medical Internet Research noted that the coaching model relies on trained support staff rather than credentialed healthcare providers 2. This matters when comparing Noom's per-month price to programs that include clinical oversight.

Noom Med: The GLP-1 Add-On and Its True Price Tag

Noom Med launched as a separate telehealth prescribing arm that pairs Noom's behavioral platform with GLP-1 receptor agonist medications. The service costs $149 per month on top of your base Noom subscription.

That $149 covers the telehealth consultation, provider follow-ups, and a treatment plan. It does not cover the medication. Noom Med primarily prescribes compounded semaglutide, with out-of-pocket medication costs ranging from $250 to $399 per month depending on dose and pharmacy. Branded Wegovy, if prescribed, runs $1,349 per month at list price without insurance according to Novo Nordisk's published wholesale acquisition cost.

The total annual cost for a Noom Med user on compounded semaglutide breaks down this way: $209 (annual coaching) plus $1,788 (Noom Med fee at $149 times 12) plus $3,000 to $4,788 (medication at $250 to $399 times 12). That puts the all-in range at approximately $5,000 to $6,800 per year. By comparison, direct GLP-1 telehealth platforms like Ro, Hims, and Henry Meds charge $199 to $399 per month with medication included, and they do not require a separate coaching subscription 3.

Noom Med does not accept insurance. Patients using employer-sponsored health savings accounts (HSAs) or flexible spending accounts (FSAs) may be able to apply those funds, but this varies by plan administrator.

What the Clinical Evidence Says About Noom's Coaching Program

Noom's most-cited clinical study is a 2016 retrospective analysis of 35,921 app users published in Scientific Reports. In that study, 77.9% of participants reported body weight reduction during their time using the app 4. The number sounds impressive in isolation. Context changes the picture.

That study was retrospective, lacked a control group, and relied on self-reported data from users who voluntarily logged their weight. Selection bias is a real concern: users who stopped logging (often those not losing weight) dropped out of the dataset. A 2020 study by Michaelides et al. in JMIR mHealth and uHealth examined 28,189 Noom users with overweight or obesity and found an average weight loss of approximately 3.4% of starting body weight over a median of 267 days 5. Completers lost more. But completers always do.

For comparison, the STEP-1 trial (N=1,961) demonstrated that semaglutide 2.4 mg produced a mean weight loss of 14.9% at 68 weeks versus 2.4% with placebo 6. The SURMOUNT-1 trial (N=2,539) showed tirzepatide at the highest dose yielded 22.5% mean weight loss at 72 weeks 7. A 3 to 5% weight loss from behavioral coaching alone is clinically meaningful by the standards of the 2013 AHA/ACC/TOS obesity management guidelines, which define a 5% threshold as the minimum for cardiometabolic benefit 8. But it is a different magnitude than pharmacotherapy.

The Diabetes Prevention Program (DPP) trial, often considered the gold standard for intensive lifestyle intervention, achieved 7% weight loss at 1 year through in-person counseling and structured physical activity 9. Noom's digital-only results fall short of that benchmark. Dr. Katherine Saunders, co-founder of Intellihealth and clinical faculty at Weill Cornell Medicine, has stated: "App-based programs can support weight management, but the magnitude of weight loss from behavioral apps alone typically does not match structured clinical programs or pharmacotherapy."

Noom vs. Alternatives: A Cost-per-Outcome Comparison

Comparing value across weight loss programs requires looking at both what you pay and what you lose. The math favors different programs depending on your starting point and goals.

Noom Coaching Only: At $209 per year with an expected 3 to 5% body weight loss, a 200-pound user might lose 6 to 10 pounds. That works out to roughly $21 to $35 per pound lost. WeightWatchers Digital: At approximately $276 per year ($23/month), clinical trial data from the WRAP trial (N=1,267) published in The Lancet showed 4.75 kg (about 10.5 lb) mean weight loss at 12 months 10. Cost per pound: approximately $26. Direct GLP-1 telehealth (e.g., Ro Body, Hims): At $249 to $399 per month (medication included), 15% weight loss in a 200-pound individual equals 30 pounds over roughly 15 months. Cost per pound: roughly $125 to $200, but the absolute weight loss is three to five times greater.

Dr. Fatima Cody Stanford, obesity medicine physician at Massachusetts General Hospital and associate professor at Harvard Medical School, has noted: "The question is not just cost per month. It is cost per clinically meaningful outcome. For patients with a BMI of 30 or above, the combination of pharmacotherapy and behavioral support produces results that behavioral support alone cannot match." 11.

For someone with a BMI of 25 to 27 seeking modest weight management, Noom's coaching subscription at $17 per month annually may offer reasonable value. For someone with a BMI of 35 and obesity-related comorbidities, the 3 to 5% loss expected from coaching alone is unlikely to produce the 10%+ weight reduction associated with improvements in obstructive sleep apnea, type 2 diabetes remission, and NASH resolution 12.

Is Noom Legit? Consumer Complaints and Red Flags

Noom is a legitimate company. It is not a scam. But its business practices have drawn regulatory and consumer attention.

The auto-renewing free trial has been a consistent source of complaints. The Better Business Bureau lists Noom with over 2,800 complaints, many related to unexpected charges after the 14-day trial period and difficulty canceling subscriptions. The New York Attorney General's office reached a settlement with Noom in 2023 over allegations that the company made it unreasonably difficult for consumers to cancel recurring charges and obtain refunds.

On clinical legitimacy, Noom's approach is grounded in established behavioral science principles (CBT, motivational interviewing), and the company has published peer-reviewed research. The issue is less about legitimacy than about expectation management. Noom's marketing has historically emphasized dramatic before-and-after stories that may not represent typical outcomes. The FTC's Health Products Compliance Guidance requires that weight loss advertisements reflect outcomes achievable by typical users, not just exceptional responders 13.

Trustpilot reviews show a mixed picture: Noom holds a 3.5 out of 5 rating with common praise for the educational content and common criticism for billing practices and limited coach interaction.

Who Gets Real Value from Noom

Noom works best for a specific user profile. Not everyone.

The strongest candidate for Noom's coaching-only plan is someone with a BMI between 25 and 29.9 who has never attempted structured behavior change for weight management, who responds well to self-directed digital learning, and whose primary barrier is mindless eating or portion awareness rather than metabolic or hormonal dysfunction. Research from the Look AHEAD trial (N=5,145) confirmed that intensive lifestyle intervention produced greater sustained weight loss in participants with lower baseline BMI and shorter duration of obesity 14.

Noom Med makes more clinical sense for patients who want behavioral support integrated with GLP-1 therapy. The SELECT trial (N=17,604) demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease 15. Behavioral adherence support could theoretically improve medication persistence, though Noom has not published data on Noom Med retention or outcomes as a combined program.

The weakest candidate is someone with class III obesity (BMI 40+) or obesity with multiple comorbidities who needs comprehensive metabolic care, lab monitoring, and potential medication titration adjustments. Noom Med's telehealth model does not include routine lab work, and the non-clinical coaching team cannot manage medication side effects.

Hidden Costs and Cancellation Realities

Several costs are not obvious at sign-up. The free trial requires a credit card. The annual plan is billed as a lump sum with no monthly payment option. Cancellation mid-cycle does not generate a prorated refund, per Noom's published terms of service.

For Noom Med specifically, compounded semaglutide pricing may change during treatment as doses titrate upward. Starting doses are cheaper. A patient beginning at 0.25 mg semaglutide weekly and titrating to the maintenance dose of 2.4 mg may see monthly medication costs increase by 30 to 60% over the first 16 weeks. Noom's published pricing does not always make this dose-dependent cost escalation clear.

Insurance coverage for GLP-1 medications prescribed through Noom Med remains a barrier. The Obesity Action Coalition's 2024 survey found that only 48% of commercially insured patients could obtain coverage for anti-obesity medications, and coverage rates for telehealth-prescribed compounded versions are lower still 16.

If you are considering Noom Med for GLP-1 access, compare the total 12-month cost against your insurance formulary. If your plan covers branded Wegovy or Zepbound with a $25 to $100 copay, a traditional in-person obesity medicine provider will cost less and provide more comprehensive care, including labs, physical exams, and direct physician management.